logo

Arrowhead Pharmaceuticals Inc. (ARWR)



Trade ARWR now with
  Date
  Headline
5/2/2022 7:35:23 AM Arrowhead Pharma Appoints Victoria Vakiener To Board
2/17/2022 7:47:12 AM Arrowhead Pharma Presents Clinical Data On ARO-HIF2 At ASCO GU 2022
1/12/2022 7:33:26 AM Arrowhead Pharma Initiates Phase 3 PALISADE Study Of ARO-APOC3 For Treatment Of Familial Chylomicronemia Syndrome
6/21/2021 7:37:34 AM Arrowhead Pharma, Horizon Therapeutics Announce Global Collaboration And License Agreement For ARO-XDH
6/3/2021 7:34:33 AM Arrowhead Pharma Initiates Phase 2b Study Of Investigational ARO-APOC3 For Treatment Of Severe Hypertriglyceridemia
10/17/2018 7:18:43 AM William Blair Reiterates Arrowhead Pharmaceuticals Inc. (ARWR) At Outperform
1/5/2018 1:21:34 PM B. Riley FBR Starts Arrowhead Pharmaceuticals Inc. (ARWR) At Buy With $3.00 Price Target
9/18/2017 10:38:21 AM William Blair Upgrades Arrowhead Pharmaceuticals Inc. (ARWR) To Outperform From Market Perform
11/30/2016 6:08:08 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) FY 18 Estimate To -0.56 From -1.18
11/30/2016 6:07:57 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) FY 17 Estimate To -0.26 From -0.96
11/30/2016 6:07:44 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q4 17 Estimate To -0.13 From -0.42
11/30/2016 6:07:20 AM Jefferies Is Raising Arrowhead Pharmaceuticals Inc. (ARWR) Q3 17 Estimate To -0.15 From -0.38
11/30/2016 6:07:08 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q2 17 Estimate To -0.20 From -0.34
11/30/2016 6:06:53 AM Jefferies Is Increasing Arrowhead Pharmaceuticals Inc. (ARWR) Q1 17 Estimate To 0.22 From 0.18
8/10/2016 8:30:49 AM RBC Capital Markets Is Increasing Arrowhead Research Corp. (ARWR) 2017 Estimate To -1.26 From -1.27
8/10/2016 8:30:22 AM RBC Capital Markets Is Raising Arrowhead Research Corp. (ARWR) 2016 Estimate To -1.30 From -1.33
5/11/2016 7:56:29 AM RBC Capital Markets Is Raising Arrowhead Research Corp. (ARWR) 2017 Estimate To -1.27 From -1.38